Form 4: Tandem Diabetes Care Executive Mark Novara Reports Routine Stock Transactions

Mark Novara, EVP & Chief Commercial Officer of Tandem Diabetes Care Inc., reported the vesting and subsequent tax-related withholding of restricted stock units.

Summary

• Mark Novara, EVP & Chief Commercial Officer of Tandem Diabetes Care Inc. (TNDM), reported transactions involving common stock and restricted stock units (RSUs).
• On June 16, 2025, Mr. Novara acquired 7,414 shares of common stock through the exercise/conversion of derivative securities (RSUs) at a price of $0.
• Concurrently, 3,846 shares of common stock were disposed of at a price of $20.76 to satisfy tax withholding requirements related to the RSU vesting.
• No shares were sold by Mr. Novara; the disposition was solely for tax purposes.
• Following these transactions, Mr. Novara directly beneficially owns 28,763 shares of common stock.
• He also beneficially owns 44,488 Restricted Stock Units.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it reflects a routine executive compensation event (vesting of RSUs) and the disposition of shares was solely for tax purposes, not a sale by the executive, which generally indicates continued alignment with shareholder interests.

Positives

• The transaction represents a routine vesting of restricted stock units, indicating the executive's continued participation in the company's long-term incentive plan.
• The disposition of shares was solely for tax withholding, not a sale by the executive, which can be viewed positively as it doesn't indicate a reduction in personal investment intent.

Negatives

• A net decrease of 3,846 shares in direct common stock holdings due to tax withholding.

Future Outlook

The remaining Restricted Stock Units will vest in eight equal quarterly installments after December 15, 2024.

Industry Context

NA

Stakeholder Impact

• Shareholders: The transaction reflects a routine compensation event for a key executive, which can be seen as a mechanism for retaining talent and aligning management interests with long-term company performance.

Next Steps

• Remaining Restricted Stock Units (RSUs) will vest in eight equal quarterly installments following the initial 33% vesting on December 15, 2024.

Key Dates

Keywords

Tandem Diabetes Care, TNDM, SEC Form 4, Insider Trading, Restricted Stock Units, RSU, Executive Compensation, Stock Vesting, Mark Novara, Common Stock